Oruka Therapeutics, Inc. (ORKA) Stock Overview
Explore Oruka Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Oruka Therapeutics, Inc. (ORKA)
Key Financials
Key Financials
Market Cap
6.7B
P/E Ratio
-44.50
EPS (TTM)
$-1.94
ROE
-0.21%
ORKA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Oruka Therapeutics, Inc. (NASDAQ: ORKA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Oruka Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ORKA on the NASDAQ shows an RSI of 74.40, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $34.82 for the NASDAQ listing.
Key metrics behind Oruka Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -44.50 and a market capitalization of 6.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ORKA on the NASDAQ.